Birdwatch Note
2024-10-14 13:31:07 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Listed among the limitations of the study cited in the article is this important caveat: "the population prevalence of pediatric PASC cannot be determined with the current design because participants with more prolonged symptoms may have been more inclined to enroll." https://x.com/onehorseblind/status/1845691495560744996 https://jamanetwork.com/journals/jama/article-abstract/2822770
Written by A02A42E7C76438897E2DA160347364F9E8F3080891948B9EB64B3F64CBA4E348
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1845515745721241810
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1845819628641017993
- noteId - 1845819628641017993
- participantId -
- noteAuthorParticipantId - A02A42E7C76438897E2DA160347364F9E8F3080891948B9EB64B3F64CBA4E348 Participant Details
- createdAtMillis - 1728912667795
- tweetId - 1845515745721241810
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Listed among the limitations of the study cited in the article is this important caveat: "the population prevalence of pediatric PASC cannot be determined with the current design because participants with more prolonged symptoms may have been more inclined to enroll." https://x.com/onehorseblind/status/1845691495560744996 https://jamanetwork.com/journals/jama/article-abstract/2822770
Note Ratings
rated at | rated by | |
2024-10-16 11:07:20 -0500 | Rating Details | |
2024-10-16 07:49:08 -0500 | Rating Details | |
2024-10-16 06:50:04 -0500 | Rating Details | |
2024-10-16 02:47:58 -0500 | Rating Details | |
2024-10-15 22:13:57 -0500 | Rating Details | |
2024-10-15 00:39:54 -0500 | Rating Details | |
2024-10-14 23:33:01 -0500 | Rating Details | |
2024-10-14 23:20:31 -0500 | Rating Details | |
2024-10-14 23:01:29 -0500 | Rating Details | |
2024-10-14 17:23:14 -0500 | Rating Details | |
2024-10-14 14:14:33 -0500 | Rating Details | |
2024-10-14 11:01:53 -0500 | Rating Details | |
2024-10-14 09:01:21 -0500 | Rating Details | |
2024-10-14 08:50:47 -0500 | Rating Details | |
2024-10-14 08:42:15 -0500 | Rating Details | |
2024-10-14 08:33:51 -0500 | Rating Details | |
2024-10-21 08:30:19 -0500 | Rating Details | |
2024-10-16 07:33:45 -0500 | Rating Details | |
2024-10-15 03:26:49 -0500 | Rating Details | |
2024-10-15 02:30:42 -0500 | Rating Details | |
2024-10-14 13:07:14 -0500 | Rating Details | |
2024-10-14 12:50:52 -0500 | Rating Details | |
2024-10-14 12:21:07 -0500 | Rating Details | |
2024-10-14 12:18:40 -0500 | Rating Details | |
2024-10-14 11:49:22 -0500 | Rating Details | |
2024-10-14 11:14:11 -0500 | Rating Details | |
2024-10-14 10:32:19 -0500 | Rating Details | |
2024-10-14 09:35:18 -0500 | Rating Details | |
2024-10-14 08:42:28 -0500 | Rating Details | |
2024-10-15 12:55:09 -0500 | Rating Details | |
2024-10-15 11:08:44 -0500 | Rating Details | |
2024-10-15 08:19:28 -0500 | Rating Details | |
2024-10-15 04:50:22 -0500 | Rating Details | |
2024-10-15 02:15:20 -0500 | Rating Details | |
2024-10-14 21:09:29 -0500 | Rating Details | |
2024-10-14 19:56:56 -0500 | Rating Details | |
2024-10-14 19:46:17 -0500 | Rating Details | |
2024-10-14 19:37:13 -0500 | Rating Details | |
2024-10-14 18:15:07 -0500 | Rating Details | |
2024-10-14 16:14:30 -0500 | Rating Details | |
2024-10-14 16:00:56 -0500 | Rating Details | |
2024-10-14 14:27:08 -0500 | Rating Details | |
2024-10-14 11:52:27 -0500 | Rating Details | |
2024-10-14 10:54:10 -0500 | Rating Details | |
2024-10-14 10:48:44 -0500 | Rating Details | |
2024-10-14 10:40:44 -0500 | Rating Details | |
2024-10-14 10:21:12 -0500 | Rating Details | |
2024-10-14 09:06:18 -0500 | Rating Details | |
2024-10-14 08:57:07 -0500 | Rating Details | |
2024-10-18 23:23:01 -0500 | Rating Details | |
2024-10-15 19:32:56 -0500 | Rating Details | |
2024-10-15 00:26:06 -0500 | Rating Details | |
2024-10-14 20:26:59 -0500 | Rating Details | |
2024-10-14 19:29:45 -0500 | Rating Details | |
2024-10-14 19:28:42 -0500 | Rating Details | |
2024-10-14 18:33:51 -0500 | Rating Details | |
2024-10-14 14:49:37 -0500 | Rating Details | |
2024-10-14 14:38:04 -0500 | Rating Details | |
2024-10-14 12:15:58 -0500 | Rating Details | |
2024-10-14 11:38:07 -0500 | Rating Details | |
2024-10-14 11:29:07 -0500 | Rating Details | |
2024-10-14 11:26:21 -0500 | Rating Details | |
2024-10-14 10:39:19 -0500 | Rating Details | |
2024-10-14 10:34:48 -0500 | Rating Details | |
2024-10-14 10:33:14 -0500 | Rating Details | |
2024-10-14 09:16:52 -0500 | Rating Details | |
2024-10-14 08:59:10 -0500 | Rating Details | |
2024-10-14 08:56:58 -0500 | Rating Details | |
2024-10-19 17:10:02 -0500 | Rating Details | |
2024-10-15 21:50:24 -0500 | Rating Details | |
2024-10-15 13:57:49 -0500 | Rating Details | |
2024-10-15 09:28:35 -0500 | Rating Details | |
2024-10-15 03:32:37 -0500 | Rating Details | |
2024-10-15 02:38:00 -0500 | Rating Details | |
2024-10-14 19:43:49 -0500 | Rating Details | |
2024-10-14 18:09:00 -0500 | Rating Details | |
2024-10-14 16:52:40 -0500 | Rating Details | |
2024-10-14 16:39:20 -0500 | Rating Details | |
2024-10-14 15:52:07 -0500 | Rating Details | |
2024-10-14 15:39:57 -0500 | Rating Details | |
2024-10-14 15:30:41 -0500 | Rating Details | |
2024-10-14 13:14:04 -0500 | Rating Details | |
2024-10-14 12:35:12 -0500 | Rating Details | |
2024-10-14 10:48:18 -0500 | Rating Details | |
2024-10-14 10:46:22 -0500 | Rating Details | |
2024-10-14 08:59:31 -0500 | Rating Details |